ProQR Therapeutics NV (PRQR)
1.335
+0.10
(+7.66%)
USD |
NASDAQ |
Oct 27, 16:00
1.32
-0.02
(-1.12%)
After-Hours: 20:00
ProQR Therapeutics Price to Book Value : 2.073 for Oct. 27, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 1.926 |
| October 23, 2026 | 2.003 |
| October 22, 2026 | 2.066 |
| October 21, 2026 | 2.128 |
| October 20, 2026 | 2.143 |
| October 19, 2026 | 2.034 |
| October 16, 2026 | 2.034 |
| October 15, 2026 | 2.252 |
| October 14, 2026 | 2.283 |
| October 13, 2026 | 2.298 |
| October 12, 2026 | 2.516 |
| October 09, 2026 | 2.532 |
| October 08, 2026 | 2.438 |
| October 07, 2026 | 2.532 |
| October 06, 2026 | 2.563 |
| October 05, 2026 | 2.594 |
| October 02, 2026 | 2.539 |
| October 01, 2026 | 2.532 |
| September 30, 2026 | 2.578 |
| September 29, 2026 | 2.563 |
| September 28, 2026 | 2.563 |
| September 25, 2026 | 2.563 |
| September 24, 2026 | 2.656 |
| September 23, 2026 | 2.640 |
| September 22, 2026 | 2.951 |
| Date | Value |
|---|---|
| September 21, 2026 | 2.889 |
| September 18, 2026 | 2.842 |
| September 17, 2026 | 2.935 |
| September 16, 2026 | 2.889 |
| September 15, 2026 | 2.858 |
| September 14, 2026 | 2.889 |
| September 11, 2026 | 2.889 |
| September 10, 2026 | 3.013 |
| September 09, 2026 | 3.091 |
| September 08, 2026 | 3.184 |
| September 04, 2026 | 3.215 |
| September 03, 2026 | 3.246 |
| September 02, 2026 | 3.339 |
| September 01, 2026 | 3.292 |
| August 31, 2026 | 3.308 |
| August 28, 2026 | 3.556 |
| August 27, 2026 | 3.603 |
| August 26, 2026 | 3.650 |
| August 25, 2026 | 3.696 |
| August 24, 2026 | 3.774 |
| August 21, 2026 | 3.634 |
| August 20, 2026 | 3.525 |
| August 19, 2026 | 3.448 |
| August 18, 2026 | 3.339 |
| August 17, 2026 | 2.997 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pharming Group NV | 3.247 |
| NewAmsterdam Pharma Co. NV | 3.820 |
| argenx SE | -- |
| Mirum Pharmaceuticals, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 2.656 |
Price to Book Value Related Metrics
| PS Ratio | 6.612 |
| PEG Ratio | -0.6288 |
| Price | 1.335 |
| Earnings Yield | -34.74% |
| Market Cap | 188.40M |
| PEGY Ratio | -0.6288 |